Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup, Inc. (ATR) delivers innovative dispensing systems and packaging solutions for pharmaceutical, beauty, and consumer goods markets worldwide. This page provides centralized access to official company announcements, financial updates, and industry developments.
Investors and stakeholders will find timely updates including earnings reports, product innovations, and strategic partnerships. Our curated news collection simplifies tracking regulatory milestones and market trends impacting AptarGroup's core segments: Pharma, Beauty, and Closures.
All content is sourced from verified corporate communications and reputable financial publications. Bookmark this page for efficient monitoring of ATR's operational developments, sustainability initiatives, and leadership changes within the global packaging industry.
AptarGroup, Inc. (NYSE: ATR) has been recognized in 3BL Media’s 100 Best Corporate Citizens ranking, highlighting its leadership and transparency in environmental, social, and governance (ESG) practices. The ranking evaluates major U.S. companies based on various ESG criteria. Aptar emphasizes its commitment to sustainability, aligning with United Nations Global Compact principles. President and CEO Stephan B. Tanda expressed pride in their corporate citizenship efforts, while Vice President Beth Holland noted ongoing commitments to stakeholder communication and global sustainability goals.
AptarGroup, Inc. (NYSE:ATR) announced a 5% price increase for its beauty, personal care, and home care products, effective June 1, 2021. This decision responds to sustained cost inflation on non-raw material inputs, including freight, energy, and labor. Marc Prieur, President of Aptar Beauty + Home, emphasized the necessity of these adjustments due to unprecedented cost increases and efforts to ensure safe production amid the COVID-19 pandemic. Sales representatives will provide customers with more details on the price changes.
AptarGroup, Inc. (NYSE:ATR) reported an 8% increase in first-quarter 2021 sales, totaling $777 million. Core sales rose 1%, driven by strong demand in the Food + Beverage segment. Reported earnings per share jumped 48% to $1.24, boosted by a non-cash gain of $0.19 per share from an equity investment. Adjusted earnings per share increased 10% to $1.09. The company expects second-quarter EPS guidance between $0.91 to $0.99, reflecting ongoing challenges in prescription drug markets but optimistic long-term growth potential. A quarterly dividend was increased by 6% to $0.38 per share.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, representing a 6% increase from the previous dividend. The payment date is May 19, 2021, for stockholders of record as of April 28, 2021. In 2020, Aptar returned $93 million to shareholders and is set for its 28th consecutive year of increased annual dividends. The company achieved a Total Shareholder Return of 102% over the past five years, outperforming its peer group and the S&P Midcap 400.
AptarGroup, Inc. (NYSE:ATR) reported strong fourth quarter results with reported sales growing 12% to $749 million. Core sales increased 5%, driven by demand in Pharma and Food & Beverage segments. Earnings per share rose 8% to $0.79. For the year, reported sales grew 2% to $2.93 billion, but earnings per share fell 12% to $3.21 due to pandemic impacts. The company achieved record cash flow from operations of $570 million and declared a quarterly dividend of $0.36 per share, highlighting its commitment to shareholders.
AptarGroup (NYSE: ATR) announces a partnership with CARE® to support global health initiatives, including the Fast + Fair COVID-19 Vaccine Response Campaign. This initiative aims to ensure equitable vaccine access for over 100 million people, focusing on women, impoverished communities, and healthcare workers across 10 countries. Aptar’s sponsorship emphasizes its commitment to diversity, inclusion, and women's empowerment, while aligning with its business model of producing vaccine delivery components. The collaboration promises to enhance CARE's efforts in advocating for equitable health policies worldwide.
AptarGroup, Inc. (NYSE: ATR) has announced that its Activ-Film™ technology will protect a new SARS Rapid Antigen test for COVID-19, recently granted Emergency Use Authorization (EUA) by the FDA. This QuickVue® SARS Antigen test, developed by Quidel® Corporation, delivers results in just 10 minutes, enhancing access to affordable COVID-19 testing, especially in schools and rural areas. Activ-Film™ integrates material science to ensure test accuracy by protecting against moisture and environmental factors. Aptar is dedicated to providing critical healthcare solutions during the pandemic.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.36 per share, payable on February 17, 2021, to stockholders of record as of January 27, 2021. The company will also hold a conference call on February 19, 2021, at 8:00 a.m. Central Time to discuss its fourth quarter and year-end results for 2020. Additionally, the 2021 Annual Meeting of Stockholders will be held virtually on May 5, 2021, at 9:00 a.m. Central Time, with a record date for voting set for March 12, 2021.
AptarGroup, Inc. (NYSE: ATR) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, with a virtual presentation at 2:50 p.m. (EST) by key executives including President and CEO Stephan Tanda. A live webcast will be available in the Investors section of the Aptar website and a replay will be accessible for 90 days post-event. Aptar is a global leader in drug delivery and packaging solutions, headquartered in Crystal Lake, Illinois, employing 14,000 people across 19 countries.
